Intensity Therapeutics Inc
NASDAQ:INTS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intensity Therapeutics Inc
NASDAQ:INTS
|
US |
|
C
|
Cohen Development Gas & Oil Ltd
TASE:CDEV
|
IL |
|
B
|
Boutique Newcity PCL
SET:BTNC
|
TH |
|
A
|
Ananda Development PCL
SET:ANAN
|
TH |
|
G
|
Global Consumer PCL
SET:GLOCON
|
TH |
|
P
|
Praram 9 Hospital PCL
SET:PR9
|
TH |
|
P
|
Petratherm Ltd
ASX:PTR
|
AU |
|
C
|
CPL Group PCL
SET:CPL
|
TH |
|
S
|
Sunsweet PCL
SET:SUN
|
TH |
|
S
|
Star Petroleum Refining PCL
SET:SPRC
|
TH |
|
E
|
Earth Tech Environment PCL
SET:ETC
|
TH |
|
Intiland Development Tbk PT
IDX:DILD
|
ID |
|
Spir Group ASA
OSE:SPIR
|
NO |
|
C
|
Compagnie de Saint Gobain SA
XMUN:GOB
|
FR |
|
Vastned Retail NV
F:VB2
|
NL |
|
MAP Aktif Adiperkasa Tbk PT
IDX:MAPA
|
ID |
|
Y
|
Yara International ASA
DUS:IU2
|
NO |
Bankruptcy Probability
Intensity Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Intensity Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
I
|
Intensity Therapeutics Inc
NASDAQ:INTS
|
12.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
467.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
182.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
81B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Intensity Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Intensity Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
